Former VP of Market Research and Patient Strategies, AstraZeneca
Diane Elizabeth Sullivan is an accomplished commercial executive with extensive leadership experience and proven success in life sciences (AstraZeneca, Pfizer, GlaxoSmithKline), consumer healthcare (GlaxoSmithKline) and technology (IBM) at US and UK domiciled global corporations. She has a reputation as a strategic thinker who has led US and global functions with sales of $2 to $20B and who consistently grows businesses and builds high performing teams.
Diane’s expertise in customer-focused and patient-centered strategy setting and operational excellence enables delivery of new capabilities that differentiate a company’s portfolio and brands. She has led teams through turbulent times in sales, marketing, market access and business development inclusive of acquisition and licensing negotiations, due diligence and integration. Diane has launch and in-line experience from rare disease to blockbusters in most therapeutic areas. She is a highly regarded leader who inspires entrepreneurial thinking and behaviors that foster an environment where talent can do their best work.
Most recently, Diane was Vice President of Market Access and Patient Strategies at AstraZeneca and a member of the North America Leadership Team responsible for sales of $20B and 500+ customer relationships. Under her leadership of 360 colleagues, AZ’s ranking improved +4 with external customers, engagement scores improved +20 points and her teams were awarded 3 Presidents Awards and the 2016 CEO Award.